Company news

Optimi Health Corp. (CSE:OPTI) news

Optimi Health Corp. news releases on 6ix. Latest, Sep 16, 2026: Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy…

Optimi Health Corp. (CSE:OPTI) news

Press releases & updates

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Optimi Health Establishes Discretionary Equity Facility

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia

Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Diamond Equity Research Initiates Coverage on Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN)

Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date

Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering

Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting

Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing

Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products

Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering

Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia

Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression

Optimi Health Reports First MDMA-Assisted Treatments of 2026 are Underway Across an Expanded Network of Australian Clinics

Optimi Health Completes MDMA Export for PTSD Treatment Under Australia's Authorised Prescriber Scheme

Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules

Early Warning Press Release in Accordance with National Instrument 62-103

Optimi Health Announces Equity Incentive Grants and Corporate Update

Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026

Optimi Health Announces Appointment of New Director

Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD

Optimi Health Provides Corporate Update

Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program

Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering

Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression

Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

Optimi Health Obtains U.S. FDA Drug Establishment Registration

OPTEC International Receives Increased Interest In The Company's Fuel Maximizer Products Due To Record Breaking Global Fuel Price Increase

OPTEC International Inc Announces Significant 28% Single Asset Increase of $700,000 In less than Nine Months

OPTEC INTERNATIONAL INTRODUCES Company's New Marketplace Website

OPTEC To Debut Company's Patented Cell Phone and Tablet Digital Temperature Scanning Technology Prototypes in March 2022

OPTEC Signs Amicable Settlement with Weshield & Collaberation of PPE Sales Agreement

OPTEC Announces Surge in PPE Product Demand

Optec International, Inc Corporate Update OPTEC Cancels 30,000 Preferred Shares

OPTEC INTERNATIONAL Inc OPTEC CEO To Retire from Board of Directors

OPTEC INTERNATIONAL Inc OTC Markets Status

OPTEC INTERNATIONAL Inc Annual Report Information Statement

WeShield Responds To OPTEC International, Inc. Information Statement

OPTEC INTERNATIONAL Inc Information Statement

Optec International Optec's Z2O Division Territories Report

This Week on MoneyTV with Donald Baillargeon, 9/17

OPTEC INTERNATIONAL Signs LOI for Acquisition of Established Medical Supply Company to Localize Same Day Deliveries

Optec International Share Issuance Correction